LRCXVSPCSA• 3 Months (Normalized)
LRCX vs PCSA (Lam Research Corporation vs Processa Pharmaceuticals Inc.)
Showing Closing Date Range from Jun, 13 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LRCX Performance $298.22
-23.32%
Lam Research Corporation
Normalized Baseline0.00%
PCSA Performance $2.08
-5.88%
Processa Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin PCSA LEADS
-17.44%
PCSA outperforming by 17.44%
LRCXPCSA
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LRCX PCSA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | LRCX Price | LRCX Gain (%) | PCSA Price | PCSA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $298.22 | -23.32% | $2.08 | -5.88% | -17.44% |
| Sep 10, 2026 | $298.01 | -23.37% | $1.85 | -16.29% | -7.08% |
| Sep 09, 2026 | $315.84 | -18.79% | $1.99 | -9.95% | -8.84% |
| Sep 08, 2026 | $320.42 | -17.61% | $2.16 | -2.26% | -15.35% |
| Sep 04, 2026 | $307.65 | -20.90% | $2.06 | -6.79% | -14.11% |
| Sep 03, 2026 | $292.66 | -24.75% | $2.05 | -7.24% | -17.51% |
| Sep 02, 2026 | $288.32 | -25.87% | $2.10 | -4.98% | -20.89% |
| Sep 01, 2026 | $290.20 | -25.38% | $2.05 | -7.24% | -18.14% |
| Aug 31, 2026 | $301.49 | -22.48% | $2.05 | -7.24% | -15.24% |
| Aug 28, 2026 | $301.90 | -22.37% | $2.06 | -6.79% | -15.58% |
| Aug 27, 2026 | $318.58 | -18.09% | $2.11 | -4.52% | -13.57% |
| Aug 26, 2026 | $312.88 | -19.55% | $2.13 | -3.62% | -15.93% |
| Aug 25, 2026 | $314.66 | -19.09% | $2.18 | -1.36% | -17.73% |
| Aug 24, 2026 | $310.17 | -20.25% | $2.17 | -1.81% | -18.44% |
| Aug 21, 2026 | $314.00 | -19.26% | $2.08 | -5.88% | -13.38% |
Page 1 of 5